483 Novartis Pharma AG Jul 2012

483 Novartis Pharma AG Jul 2012

Brandon Heitmeier FDA, Prabhu Raju FDA, Helen Ricalde FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharma AG - Basel, Switzerland facility and issued inspectional observations (via FDA 483) on 26 Jul 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Jul 2012
  • Location: Basel, Switzerland
  • FEI: 3007303963
Add To Cart